Delivery Order SPE2DB20D3304-SPE2DB25FW9A7
- Not listed
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This non-set-aside, competitively awarded contract employs firm fixed price terms with an ultimate completion date of August 27, 2025. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,853.49. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is non-competitive and issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Lyrica 100 mg capsules (quantity: 90 units) with a ceiling value of $2,514.26. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract is scheduled for ultimate completion on...
- The Defense Logistics Agency awarded a $3,551.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 200 mg capsules (90-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lyrica 100 mg capsules (90 count) with a contract value of $4,272.77. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) valued at $2,530.67. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was awarded competitively with no set-aside designation, and the...
- The Defense Logistics Agency awarded a delivery order valued at $4,746.84 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- The Defense Logistics Agency awarded a $3,342.80 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW9A7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal procurement presence supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a critical vendor for federal medical procurement, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains through its DLA contracts. This delivery order for Lyrica, a neurological treatment medication, exemplifies the company's ongoing role in fulfilling pharmaceutical supply requirements for military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/15/25 |